Related Experiment Video
Updated: Jul 15, 2026
09:49
Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
Pneumonia observational incidence and treatment: a multidisciplinary process improvement study
Jan Brozek1, Ellen McDonald, France Clarke
1Jagiellonian University School of Medicine and Polish Institute for Evidence Based Medicine, Krakow, Poland.
Summary
This study characterized pneumonia in intensive care unit (ICU) patients, finding most cases were community-acquired and caused by gram-positive bacteria. Improvement strategies focused on antibiotic use and information systems.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Hospital Epidemiology
Background:
- Limited data exists on pneumonia types, causes, and treatments in intensive care unit (ICU) patients during routine clinical practice.
- Understanding these aspects is crucial for improving patient outcomes and optimizing resource allocation in critical care settings.
Purpose of the Study:
- To characterize the treatment of presumed pneumonia in a tertiary care ICU.
- To identify specific areas for enhancing patient care and management strategies.
Main Methods:
- A prospective cohort study was conducted over a 3-month period, including all consecutive ICU admissions.
- Data collected included pneumonia incidence, diagnostic investigations, microbial isolates, and prescribed antibiotics for patients with presumed pneumonia.
Main Results:
- Of 194 admissions, 73 patients received pneumonia treatment: 47 community-acquired, 12 hospital-acquired, 12 ventilator-associated, and 2 ICU-acquired.
- Microbiological tests were performed on approximately 71% of patients. Gram-positive bacteria (51.9%) were the most common isolates, followed by gram-negative bacteria (31.5%) and Candida species (9.3%).
- Quinolones and cephalosporins were the most frequently prescribed antimicrobials, with patients receiving a median of 3 antibiotics.
Conclusions:
- The majority of pneumonia cases in this ICU cohort were community-acquired, with gram-positive cocci being the predominant causative organisms.
- Recommended quality improvement strategies include rationalizing antibiotic use, enhancing culture result reporting, pharmacist review of antibiotic appropriateness, and redesigning clinical information systems.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...